StemCell Institute Inc. (7096.T)
JPY 1286.0
(-7.28%)
JPY 1286.0
(-7.28%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 334.62 Million | 99.67 Million | 469.29 Million | 238.99 Million | 667.85 Million |
| Net Income | 441.32 Million | 278.95 Million | 212.55 Million | 91.44 Million | 277.48 Million |
| Depreciation & Amortization | 120.59 Million | 104.93 Million | 96.91 Million | 32.78 Million | 31.84 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -97.54 Million | -185.89 Million | 132.13 Million | 244.43 Million | 347.25 Million |
| Other non-cash items | 200 Thousand | 9.45 Million | 19.18 Million | -11.9 Million | 178.27 Million |
| Investing Cash Flow | -811.77 Million | -285.1 Million | 404.17 Million | -520.26 Million | -108 Million |
| Investments in PPE | -201.65 Million | -59.9 Million | -204.48 Million | -403.33 Million | -65.02 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -699.9 Million | -143.01 Million | - | -856.1 Million | -751 Million |
| Sales/Maturities of investments | 72.32 Million | 1 Million | 750 Million | 751 Million | 751 Million |
| Other Investing Activities | 17.45 Million | -83.18 Million | -8.29 Million | -11.82 Million | -42.98 Million |
| Financing Cash Flow | -1.33 Million | -869 Thousand | 644.37 Million | - | - |
| Debt repayment | -1.33 Million | -777 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | -91 Thousand | - | - | - |
| Common Stock Issuance | - | - | 644.37 Million | - | - |
| Other Financing Activities | -1 Million | -1000.00 | 644 Million | - | - |
| Accounts receivables | -447 Million | -546 Million | -314 Million | -908 Thousand | -100.56 Million |
| Accounts payables | 5.11 Million | 228 Thousand | 8.95 Million | -42.31 Million | 321 Thousand |
| Inventory | -2.9 Million | 796 Thousand | -8.03 Million | -15.98 Million | -3.05 Million |
| Other working capital | 337 Million | 381 Million | 400 Million | 284 Million | 450.55 Million |
| Cash at beginning of period | 3.32 Billion | 3.51 Billion | 1.99 Billion | 2.27 Billion | 1.71 Billion |
| Cash at end of period | 2.84 Billion | 3.32 Billion | 3.51 Billion | 1.99 Billion | 2.27 Billion |
| Capital Expenditure | -201.65 Million | -59.9 Million | -204.48 Million | -403.33 Million | -65.02 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -478.48 Million | -186.29 Million | 1.51 Billion | -281.26 Million | 559.85 Million |
| Free Cash Flow | 132.96 Million | 39.76 Million | 264.8 Million | -164.34 Million | 602.83 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 178 Million | 56 Million | 441.32 Million | 95 Million | 84 Million | 75 Million |
| Depreciation & Amortization | - | - | 120.59 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -97.54 Million | - | - | - |
| Other non-cash items | -178 Million | -56 Million | 200 Thousand | -95 Million | -84 Million | -75 Million |
| Investing Cash Flow | - | - | -811.77 Million | - | - | - |
| Investments in PPE | - | - | -201.65 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -699.9 Million | - | - | - |
| Sales/Maturities of investments | - | - | 72.32 Million | - | - | - |
| Other Investing Activities | - | - | 17.45 Million | - | - | - |
| Financing Cash Flow | - | - | -1.33 Million | - | - | - |
| Debt repayment | - | - | -1.33 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -1 Million | - | - | - |
| Accounts receivables | - | - | -447 Million | - | - | - |
| Accounts payables | - | - | 5.11 Million | - | - | - |
| Inventory | - | - | -2.9 Million | - | - | - |
| Other working capital | - | - | 337 Million | - | - | - |
| Cash at beginning of period | - | - | 3.32 Billion | - | - | - |
| Cash at end of period | - | - | 2.84 Billion | - | - | - |
| Capital Expenditure | - | - | -201.65 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -478.48 Million | - | - | - |
| Free Cash Flow | - | - | 132.96 Million | - | - | - |
HUBG
MGRO
ALRGR
CECO
5Y7
000755